AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Opal, SM Sypek, JP Keith, JC Schaub, RG Palardy, JE Parejo, NA
Citation: Sm. Opal et al., Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection, SHOCK, 15(4), 2001, pp. 285-290

Authors: Murray, HW Montelibano, C Peterson, R Sypek, JP
Citation: Hw. Murray et al., Interleukin-12 regulates the response to chemotherapy in experimental visceral leishmaniasis., J INFEC DIS, 182(5), 2000, pp. 1497-1502

Authors: Bancroft, AJ Artis, D Donaldson, DD Sypek, JP Grencis, RK
Citation: Aj. Bancroft et al., Gastrointestinal nematode expulsion in IL-4 knockout mice is IL-13 dependent, EUR J IMMUN, 30(7), 2000, pp. 2083-2091

Authors: Kenney, RT Sacks, DL Sypek, JP Vilela, L Gam, AA Evans-Davis, K
Citation: Rt. Kenney et al., Protective immunity using recombinant human IL-12 and alum as adjuvants ina primate model of cutaneous leishmaniasis, J IMMUNOL, 163(8), 1999, pp. 4481-4488

Authors: Thibodeaux, DK Hunter, SE Waldburger, KE Bliss, JL Trepicchio, WL Sypek, JP Dunussi-Joannopoulos, K Goldman, SJ Leonard, JP
Citation: Dk. Thibodeaux et al., Autocrine regulation of IL-12 receptor expression is independent of secondary IFN-gamma secretion and not restricted to T and NK cells, J IMMUNOL, 163(10), 1999, pp. 5257-5264

Authors: Schopf, LR Bliss, JL Lavigne, LM Chung, CL Wolf, SF Sypek, JP
Citation: Lr. Schopf et al., Interleukin-12 is capable of generating an antigen-specific Th1-type response in the presence of an ongoing infection-driven Th2-type response, INFEC IMMUN, 67(5), 1999, pp. 2166-2171

Authors: Kropf, P Schopf, LR Chung, CL Xu, DM Liew, FY Sypek, JP Muller, I
Citation: P. Kropf et al., Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection, EUR J IMMUN, 29(11), 1999, pp. 3621-3628
Risultati: 1-7 |